 |
 |
 |
 |
 |
 |
|
Applied Health Outcomes and Economics
|
Quality Improvement |
Managed Markets |
Strategic & Commercial Consulting |
Medical Communications & Key Opinion Leader (KOL) Management |
Market Research and Analytics |
|
Pharmaco-epidemiologic Studies & Analysis
> Study design
> Post-marketing surveillance studies
> Phase IV studies: drug effects or events
> Observational studies: cohort, case-control and cross-sectional
> Disease state conceptual model refinement
> Disease state prevalence and incidence studies and analysis
|
Clinical Guideline Analysis & Evaluation
> Synthesis services
> Gap analysis
> Implementation
> Engagement
|
Drug Utilization Reviews
|
Value Proposition
> Development
> Testing
|
Medical/Scientific Writing
> Manuscripts
> White Papers
> Posters
> Poster layout
> Product monographs
> Training module development
> Slide kits
> Symposia program content development (CME and non-CME)
> Enduring materials
> Scientific meeting summaries
|
Assessment Services
> Market analysis
> Opportunity analysis
> Line extension analysis
|
|
Pharmacoeconomic Modeling Studies & Analysis
> Study design
> Cost-benefit analysis
> Cost-effectiveness analysis
> Cost-minimization analysis
> Cost-utility analysis
> Burden of illness studies
> QALY studies
> Pharmacoeconomic models
- Budget impact modeling
- Markov, decision tree models
|
Knowledge Translation (KT) Services: Research to Practice
> Increasing awareness
> Promoting agreement
> Facilitating adoption
> Enhancing adherence
|
Value Dossiers
|
Knowledge, Attitudes, Beliefs & Practices (KABP) Surveys
> Design and development
> Survey management
> Data analysis and reports
|
Communications Strategies
> Strategic communications plan
> Message dissemination strategies
> Prelaunch planning
|
Market Outreach
> Planning
> Coordination
> Screening and interviewing
> IDI and focus group moderation
> Qualitative/quantitative analysis
> Discussion guide development
|
|
Clinical Research Services
> Data collection, including chart reviews
> Site monitoring and management
> Data analysis of Phase II, III and IV data
> Phase IV development and management
> Clinical efficacy analysis
|
Benchmarking
> Study design and development
> Project recruitment and management
> Data analysis and reports
|
Formulary Kits
|
Pre-Launch/Launch/Post-Launch & Re-Launch Services
> Positioning development and recommendations
> Develop messaging strategy
> Develop scientific message platform
> Develop commercial message platform
|
Marketing & Scientific Messaging
> Link scientific messaging with brand
> Optimize product awareness, desirability, acceptance
> Increase patient & physician awareness
> Improve provider-patient communication
|
Surveying
> Telephone surveying
> Personal screening
> Qualitative/quantitative analysis
|
|
Non-Interventional Studies
> Data procurement
> Study management
> Analysis and reports
> Database studies
> Observational studies
> Safety analysis
|
Performance Measures
> Development
> Testing and validation
|
Pricing, Reimbursement & Market Access Strategy
|
HEOR Strategic Planning
|
Publications Strategy
> Planning and development
> Alignment of publications plan and scientific messaging strategy
> Publication plan development and management
|
Competitive Intelligence Research
> Market warfare strategies/war games
> Competitive analysis
|
|
Clinical Effectiveness Research
> Outcomes effectiveness
> Comparative effectiveness
> Statistical sampling design
> Therapeutic optimization studies
|
Clinical Resource Utilization Management Strategies
|
Value-Based Purchasing Strategy
|
Research Impact Analysis and Contingency Planning
|
Structured Literature Reviews
> Systematic searches
> Information extraction
> Evaluation and results
> GAP analysis
|
|
|
Patient Reported Outcomes (PRO) & Research
> Development and validation of scales
> PRO study design and management
> Surveys
> Statistical sampling design
|
Preventable Adverse Event Reduction Initiatives
|
Prevention & Chronic Illness Management
|
Life Cycle Analysis
> Assess new indications
> Strategies to maximize value in life cycle
> Portfolio analysis and assessment
|
KOL Forums & Advisory Boards
> Identification and recruitment
> Advocacy training
> Content development
> Slide deck development
> Symposia and advisory board content development
|
|
|
Registries: Disease, Drug & Product
> Development and management
> Data analysis and reporting
|
Patient Safety Programs
|
Customer Programs & Training
|
Risk Mitigation Strategy (REMS)
|
Speaker Training
> Customer training
> KOL training
|
|
|
|
Coding Consultation
|
Clinical Development & Acquisition Planning & Consulting
> Product acquisition, integration and licensing services
> In licensing consulting
- Medical technology
- Molecules
> Next generation and follow-on biologic consulting
|
Field Support Services
> Tool development
> Slide presentations
> Launch kits
|
|
|
|
Commercialization Strategies
> Payer value proposition
|
Line Extension Analysis
> Pediatric
> Formulations
> New indications
> Dosing
|
Medical Field Support Services
> Field Communications
> Physician /
pharmacist/customer information requests
|
|
|
|
|
Market Mapping
|
Medical Training
> Sales training
> Customer training
> Therapeutic category education
> Disease state education and training
|
|